Healio Gastroenterology Current Issue

The following articles appeared in the print edition of Healio Gastroenterology.

Table of Contents

• ‘We Don’t Talk About It’: HBV, an Underprioritized Public Health Threat
• Should All Adults be Vaccinated Against HBV?
• 7 Recent Reports on HBV Treatment Approvals, Efficacy
• FDA Approves First Oral Liquid Treatment for C. difficile-associated Diarrhea
• FDA Approves Phase 2 Study of Ulcerative Colitis Drug Candidate
• Gastroparesis Drug Candidate Development Moves Forward With New Financing
• New Blood Test Distinguishes Between IBD, IBS
• True Health Launches New Test for Celiac, Gluten Sensitivity
• Lost in Translation: HBV Management Amid the ‘Jungle of Guidelines’ Michael S. Saag, MD
• New AGA Guideline Steers Early Treatment for Acute Pancreatitis
• Fatty Liver Index Predicts Diabetes in Absence of Impaired Fasting Glucose
• Online Decision Tool Helps IBD Patients Choose Biologic Therapy
• Vitamin D Supplements May Ease IBS Symptoms
• IBD Patients With High ‘Patient Activation’ Less Likely to Flare
• IBS-D Antibiotic Xifaxan Shows Promise in Severe Crohn’s Disease
• Liquid Biopsy Test Detects Early-stage Colorectal Cancer
• Methotrexate Fails to Prevent Relapse in Patients With UC
• VIDEO: Microbiome Research Aims to Uncover how Diet can Treat IBD
• Opioid Use ‘Alarmingly High’ Among Patients With IBD
• Oral JAK Inhibitor Xeljanz Shows Promise in Crohn’s Disease
• Patients With Psoriasis More Likely to Experience GI Symptoms
• Ramucirumab Reduces Risk for Progression in Certain Gastric Cancers
• $100 Million Needed to Fight HIV, HCV Outbreaks Due to Opioids, Organizations Say
• AGA Enrolls First Patient in Fecal Transplant Registry
• AGA Introduces app to Help Patients, Doctors Treat IBD
• FDA: Imodium Packaging Changes Needed to Stem Abuse, Misuse
• New Grant to Fund Study of Gut Microbiome, Colon Cancer